Physician
Sandhills Pediatrics
Sandhills Pediatrics was paid $32.64M by Medicaid between Jan 2018 and Dec 2024, across 102 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoSANDHILLS PEDIATRICS
SOUTHERN PINES, NC 28387
SOUTHERN PINES, NC 28387
33aNPI1114998150assigned 01/28/2006
33bProvider typeChild & Adolescent Psychiatry Physician
28Total paid$32.64M
24GClaims1,828,840
24DCodes billed102
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Child & Adolescent Psychiatry Physician providers in North Carolina
Rank by total paid#1 of 20
Median peer was paid$184K
This provider vs. median177×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 118,075 | $3.30M | |
| 2019 | 126,293 | $3.86M | |
| 2020 | 109,752 | $3.45M | |
| 2021 | 262,977 | $4.90M | |
| 2022 | 425,278 | $5.85M | |
| 2023 | 429,987 | $6.12M | |
| 2024incomplete | 356,478 | $5.15M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 130,384 | 122,287 | $7.89M |
| 99199 | Unlisted special service, procedure or report | 21% | 1,015,713 | 510,420 | $6.90M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 50,585 | 47,484 | $4.61M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.8% | 55,032 | 53,076 | $2.86M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.7% | 25,710 | 23,910 | $2.18M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.5% | 24,096 | 23,392 | $2.11M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.2% | 11,762 | 11,318 | $1.04M |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 2.2% | 8,445 | 4,980 | $711K |
| D0145 | Oral evaluation for a patient under three years of age | 1.2% | 11,951 | 11,651 | $406K |
| 99051 | 1.2% | 17,038 | 15,982 | $394K | |
| 99401 | 1.1% | 11,036 | 10,358 | $370K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 3,655 | 3,539 | $356K |
90 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.0% | 35,410 | $329K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14,115 | $271K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16,229 | $215K |
| D1206 | Topical application of fluoride varnish | <1% | 11,959 | $178K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 12,080 | $160K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,382 | $149K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 5,018 | $144K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,889 | $123K |
| 96127 | <1% | 25,899 | $113K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 894 | $112K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,292 | $111K |
| 92551 | <1% | 33,121 | $100K | |
| 85027 | <1% | 11,511 | $85K | |
| 0002A | <1% | 1,042 | $67K | |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 1,718 | $64K |
| 0001A | <1% | 941 | $57K | |
| 99173 | <1% | 36,223 | $51K | |
| 96161 | <1% | 11,729 | $42K | |
| 90686 | <1% | 28,874 | $41K | |
| 0071A | <1% | 678 | $38K | |
| 0072A | <1% | 591 | $38K | |
| 96160 | <1% | 10,800 | $38K | |
| 83655 | <1% | 2,662 | $36K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 839 | $32K |
| 90651 | <1% | 1,504 | $30K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 144 | $24K |
| 90670 | <1% | 14,854 | $19K | |
| 99070 | <1% | 2,171 | $18K | |
| 90480 | <1% | 355 | $14K | |
| 99381 | <1% | 119 | $11K | |
| 90474 | <1% | 524 | $10K | |
| 96101 | <1% | 43 | $9K | |
| 81003 | <1% | 3,473 | $9K | |
| 90656 | <1% | 2,532 | $7K | |
| 90734 | <1% | 352 | $6K | |
| 90785 | <1% | 1,189 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 487 | $5K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 217 | $5K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 46 | $4K |
| 90700 | <1% | 19,759 | $4K | |
| 90619 | <1% | 389 | $4K | |
| 90713 | <1% | 13,422 | $3K | |
| 90680 | <1% | 7,553 | $3K | |
| 94664 | <1% | 341 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 189 | $3K |
| 0054A | <1% | 61 | $3K | |
| 0124A | <1% | 49 | $3K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 44 | $2K |
| 0004A | <1% | 42 | $2K | |
| 90836 | <1% | 41 | $2K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 71 | $2K |
| 87634 | <1% | 70 | $2K | |
| E0570 | Nebulizer, with compressor | <1% | 12 | $2K |
| 90461 | <1% | 25,438 | $2K | |
| 96130 | <1% | 14 | $2K | |
| 99243 | <1% | 12 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 137 | $1K |
| 90715 | <1% | 181 | $1K | |
| 94010 | <1% | 49 | $1K | |
| 90716 | <1% | 2,720 | $1K | |
| 87807 | <1% | 77 | $1K | |
| 90647 | <1% | 7,541 | $1K | |
| 90633 | <1% | 3,469 | $735.55 | |
| 90707 | <1% | 2,709 | $524.74 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 18 | $518.55 |
| 96136 | <1% | 14 | $502.07 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,030 | $382.54 |
| 90688 | <1% | 31 | $327.00 | |
| 91322 | <1% | 18 | $263.68 | |
| 99177 | <1% | 16,129 | $247.88 | |
| 96380 | <1% | 12 | $207.38 | |
| 90744 | <1% | 2,999 | $154.86 | |
| 82247 | <1% | 16 | $104.16 | |
| 82962 | <1% | 28 | $69.36 | |
| 36416 | <1% | 26,175 | $20.14 | |
| 99072 | <1% | 8,180 | $7.00 | |
| 90677 | <1% | 329 | $2.29 | |
| 90380 | <1% | 33 | $0.11 | |
| 90381 | <1% | 24 | $0.09 | |
| 90685 | 0% | 2,143 | $0.00 | |
| 91300 | 0% | 2,500 | $0.00 | |
| 91311 | 0% | 13 | $0.00 | |
| 91321 | 0% | 73 | $0.00 | |
| 91312 | 0% | 48 | $0.00 | |
| 91308 | 0% | 12 | $0.00 | |
| 99000 | 0% | 17,222 | $0.00 | |
| 91307 | 0% | 1,779 | $0.00 | |
| 91305 | 0% | 255 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 43 | $0.00 |
| 94760 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDIASIO, CHRISTOPH (MANAGING PARTNER)